{"id":"cultured-autologous-mesenchymal-cells","safety":{"commonSideEffects":[{"rate":"null","effect":"Infusion-related reactions"},{"rate":"null","effect":"Bacterial infections"},{"rate":"null","effect":"Viral infections"}]},"_chembl":{"chemblId":"CHEMBL5315092","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action is not fully understood, but it is believed that these cells can modulate the immune response and promote tissue repair through the release of various growth factors and cytokines. This can lead to improved outcomes in various therapeutic areas.","oneSentence":"Cultured autologous Mesenchymal Cells are thought to exert their therapeutic effects through immunomodulation and tissue repair.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:29:49.444Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of graft-versus-host disease"}]},"trialDetails":[{"nctId":"NCT06798623","phase":"PHASE1","title":"Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-24","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":15},{"nctId":"NCT05651997","phase":"NA","title":"Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the Knee","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2026-12","conditions":"Articular Cartilage Defect, Chondral Defect, Osteochondritis","enrollment":80},{"nctId":"NCT06915233","phase":"PHASE3","title":"A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle","status":"RECRUITING","sponsor":"Vericel Corporation","startDate":"2026-03","conditions":"Chondral Defect, Articular Cartilage Defect","enrollment":309},{"nctId":"NCT03158896","phase":"PHASE1","title":"Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-07-09","conditions":"Acute Graft Versus Host Disease","enrollment":24},{"nctId":"NCT04312113","phase":"PHASE1","title":"Angiographic Delivery of AD-MSC for Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2020-11-16","conditions":"Ulcerative Colitis","enrollment":20},{"nctId":"NCT07157891","phase":"EARLY_PHASE1","title":"Investigating the Safety and Regenerative Potential of MSC-Derived Secretome Combined With PRGF in Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"University of the Punjab","startDate":"2025-12-10","conditions":"Osteoarthritis (OA), Knee Injury, Cartilage Degeneration","enrollment":25},{"nctId":"NCT04042844","phase":"PHASE2","title":"A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)","status":"RECRUITING","sponsor":"BioRestorative Therapies","startDate":"2022-06-30","conditions":"Lumbar Disc Disease","enrollment":99},{"nctId":"NCT05018793","phase":"PHASE1","title":"Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2024-12-01","conditions":"Spinal Cord Injuries","enrollment":15},{"nctId":"NCT05018871","phase":"PHASE1","title":"Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP","status":"SUSPENDED","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-12","conditions":"Cerebral Palsy","enrollment":15},{"nctId":"NCT06896747","phase":"PHASE1, PHASE2","title":"Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-02-21","conditions":"Thin Endometrial Lining, Female Infertility, Intrauterine Adhesions","enrollment":90},{"nctId":"NCT01842477","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2013-05","conditions":"Delayed Union After Fracture of Humerus, Tibial or Femur","enrollment":30},{"nctId":"NCT03325504","phase":"PHASE3","title":"A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union","status":"COMPLETED","sponsor":"Universidad Autonoma de Madrid","startDate":"2017-09-05","conditions":"Non Union Fracture","enrollment":46},{"nctId":"NCT03969680","phase":"NA","title":"Mesenchymal Stem Cell Transplantation for Osteoarthritis","status":"TERMINATED","sponsor":"Yantai Yuhuangding Hospital","startDate":"2019-07-08","conditions":"Knee Osteoarthritis","enrollment":2},{"nctId":"NCT06103396","phase":"PHASE1, PHASE2","title":"Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs)","status":"UNKNOWN","sponsor":"Instituto Venezolano de Investigaciones Cientificas","startDate":"2018-01-30","conditions":"Pseudoarthrosis of Bone, Pseudarthrosis, Non Union Fracture","enrollment":30},{"nctId":"NCT05975892","phase":"PHASE1, PHASE2","title":"Transplantation of Bone Marrow Mesenchymal Stromal Cells for Periodontal Regeneration","status":"UNKNOWN","sponsor":"Instituto Venezolano de Investigaciones Cientificas","startDate":"2018-08-30","conditions":"Chronic Periodontal Disease, Aggressive Periodontitis","enrollment":30},{"nctId":"NCT04744051","phase":"PHASE1","title":"ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion","status":"UNKNOWN","sponsor":"American CryoStem Corporation","startDate":"2021-02-01","conditions":"Post-Concussion Syndrome","enrollment":20},{"nctId":"NCT05850208","phase":"PHASE1","title":"Autologous Bone Marrow Mesenchymal Stem Cells (BMSCs) Transplantation in the Treatment of Ischemic Stroke","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2022-02-23","conditions":"Ischemic Stroke","enrollment":60},{"nctId":"NCT03968198","phase":"PHASE2","title":"Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia.","status":"TERMINATED","sponsor":"University Hospital, Toulouse","startDate":"2020-03-04","conditions":"Critical Limb Ischemia and Peripheral Artery Disease","enrollment":2},{"nctId":"NCT02462330","phase":"PHASE2","title":"Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2016-02-19","conditions":"Chronic Myocardial Ischemia","enrollment":39},{"nctId":"NCT04212728","phase":"NA","title":"Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells","status":"UNKNOWN","sponsor":"Yantai Yuhuangding Hospital","startDate":"2019-12-29","conditions":"Knee Osteoarthritis","enrollment":60},{"nctId":"NCT02025270","phase":"PHASE1, PHASE2","title":"MSCs For Treatment of Azoospermic Patients","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2012-10-15","conditions":"Male Infertility","enrollment":100},{"nctId":"NCT02497443","phase":"PHASE1, PHASE2","title":"Safety of Autologous MSC Infusion to Treat Epilepsy","status":"COMPLETED","sponsor":"Ministry of Public Health, Republic of Belarus","startDate":"2011-04","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT02065167","phase":"PHASE2","title":"Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip","status":"COMPLETED","sponsor":"Universidad Autonoma de Madrid","startDate":"2014-02","conditions":"Avascular Necrosis of the Femoral Head","enrollment":26},{"nctId":"NCT04876326","phase":"NA","title":"Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2020-10-05","conditions":"Multiple System Atrophy, Parkinsonism, Multiple System Atrophy, Parkinson Variant","enrollment":15},{"nctId":"NCT02566655","phase":"PHASE1","title":"Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis","status":"COMPLETED","sponsor":"Red de Terapia Celular","startDate":"2015-09","conditions":"Osteoporosis, Spinal Fractures","enrollment":10},{"nctId":"NCT02166021","phase":"PHASE2","title":"Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Dimitrios Karussis","startDate":"2015-01-29","conditions":"Multiple Sclerosis (MS)","enrollment":48},{"nctId":"NCT03066245","phase":"PHASE1, PHASE2","title":"Use of Stem Cells Cultured on a Scaffold for the Treatment of Aneurysmal Bone Cysts (ABC)","status":"UNKNOWN","sponsor":"Sophia Al-Adwan","startDate":"2018-05-03","conditions":"Aneurysmal Bone Cyst","enrollment":4},{"nctId":"NCT01051882","phase":"PHASE1, PHASE2","title":"Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.","status":"COMPLETED","sponsor":"Brainstorm-Cell Therapeutics","startDate":"2011-06","conditions":"Amyotrophic Lateral Sclerosis","enrollment":12},{"nctId":"NCT02824393","phase":"EARLY_PHASE1","title":"Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria","status":"COMPLETED","sponsor":"Celal Bayar University","startDate":"2017-03-03","conditions":"Urticaria, Autoimmune Diseases, Immune System Diseases","enrollment":10},{"nctId":"NCT03563495","phase":"NA","title":"Tissue Engineered Constructs for Alveolar Cleft Repair","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-02","conditions":"Cleft Lip and Palate","enrollment":10},{"nctId":"NCT02460770","phase":"PHASE1","title":"Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device","status":"WITHDRAWN","sponsor":"University Hospital, Toulouse","startDate":"2015-06","conditions":"Chronic Myocardial Ischemia","enrollment":""},{"nctId":"NCT03103295","phase":"PHASE1, PHASE2","title":"3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects","status":"UNKNOWN","sponsor":"A.A. Partners, LLC","startDate":"2015-11-20","conditions":"Bone Defects","enrollment":20},{"nctId":"NCT03113747","phase":"PHASE1, PHASE2","title":"Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs)","status":"UNKNOWN","sponsor":"A.A. Partners, LLC","startDate":"2015-03-25","conditions":"Second- or Third-degree Burns","enrollment":20},{"nctId":"NCT01716481","phase":"PHASE3","title":"The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2012-11","conditions":"Stroke, Ischemic","enrollment":60},{"nctId":"NCT02566681","phase":"PHASE1","title":"Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis","status":"UNKNOWN","sponsor":"Red de Terapia Celular","startDate":"2015-09","conditions":"Osteonecrosis of Jaw","enrollment":10},{"nctId":"NCT01314092","phase":"PHASE2","title":"Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula","status":"TERMINATED","sponsor":"Anterogen Co., Ltd.","startDate":"2011-01","conditions":"Complex Perianal Fistula","enrollment":15},{"nctId":"NCT02749448","phase":"PHASE1","title":"Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients","status":"UNKNOWN","sponsor":"Dr. Mostafa Ghanei","startDate":"2015-02","conditions":"Pulmonary Disease","enrollment":10},{"nctId":"NCT00908856","phase":"PHASE1","title":"Autologous Cell Therapy After Stroke","status":"WITHDRAWN","sponsor":"University of California, Irvine","startDate":"2016-01","conditions":"Stroke","enrollment":""},{"nctId":"NCT02492308","phase":"PHASE1, PHASE2","title":"Induction With SVF Derived MSC in Living-related Kidney Transplantation","status":"UNKNOWN","sponsor":"Fuzhou General Hospital","startDate":"2014-12","conditions":"Living-relative Kidney Transplantation","enrollment":120},{"nctId":"NCT02492490","phase":"PHASE1, PHASE2","title":"Effect of SVF Derived MSC in DCD Renal Transplantation","status":"UNKNOWN","sponsor":"Fuzhou General Hospital","startDate":"2014-12","conditions":"Uremia","enrollment":120},{"nctId":"NCT02107118","phase":"PHASE1","title":"Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2015-05","conditions":"Erectile Dysfunction, Cardiac Disease","enrollment":""},{"nctId":"NCT02327832","phase":"PHASE1","title":"Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs","status":"UNKNOWN","sponsor":"Yamaguchi University Hospital","startDate":"2014-12","conditions":"Liver Regeneration","enrollment":10},{"nctId":"NCT02062931","phase":"PHASE1, PHASE2","title":"Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure","status":"UNKNOWN","sponsor":"Sayed Bakry","startDate":"2012-03","conditions":"Premature Ovarian Failure","enrollment":60},{"nctId":"NCT00850187","phase":"PHASE1","title":"Autologous Transplantation of Mesenchymal Stem Cells (MSCs) and Scaffold in Full-thickness Articular Cartilage","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2008-08","conditions":"Knee Osteoarthritis","enrollment":6},{"nctId":"NCT01399749","phase":"PHASE1, PHASE2","title":"Autologous Mesenchymal Stem Cells vs. Chondrocytes for the Repair of Chondral Knee Defects","status":"UNKNOWN","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz","startDate":"2011-09","conditions":"Articular Cartilage Lesion of the Femoral Condyle","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Cultured autologous Mesenchymal Cells","genericName":"Cultured autologous Mesenchymal Cells","companyName":"Universidad Autonoma de Madrid","companyId":"universidad-autonoma-de-madrid","modality":"Biologic","firstApprovalDate":"","aiSummary":"Cultured autologous Mesenchymal Cells are thought to exert their therapeutic effects through immunomodulation and tissue repair. Used for Treatment of graft-versus-host disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}